You searched for: redwood pharma
The first move has been made – now we are waiting for answers
After months of speculation, Trump has now moved his first pawn. On one side of the board, he sits with...
Saniona's new CFO: "More deals are definitely on the horizon"
Saniona has appointed Johnny Stilou as its new Chief Financial Officer. With a career spanning over 25 years...
Hansa Biopharma appoints new Chief Operating Officer
Hansa Biopharma has appointed Maria Törnsén as Chief Operating Officer and Head of the US operations starting May 19. She will...
PharmaLundensis wants to postpone repayment
PharmaLundensis plans to negotiate an extended repayment period for a remaining convertible debt of approximately SEK 3,2 million, as the company...
Roche may reconsider $50 billion investment in the US
Swiss pharmaceutical giant Roche is considering reevaluating its promise to invest $50 billion in the United States. The reason is...
Biosergen strengthens the board with an expert in anti-infective drugs
Biosergen, a biotechnology company focused on developing treatments for life-threatening fungal infections, has nominated Dr. Marco Taglietti, MD, for...
Trump wants to cut drug prices by up to 80 percent
President Donald Trump intends to sign an executive order aimed at dramatically lowering drug prices in the United States by...
EQL Pharma sets new high goals
Lund-based EQL Pharma concludes its five-year plan with impressive growth for the broken financial year 2024/2025. With a historic acquisition...
Strong growth for Alvotech – focus on product launches
Icelandic Alvotech reports explosive sales growth of 260 percent for the first quarter of 2025 and raises its full-year forecast after acquisitions and...
Novo Nordisk lowers forecast – struggling with compounding
Novo Nordisk reports sales growth of 18 percent at constant exchange rates for the first quarter of 2025. At the same time, the company lowers its full-year forecast...
Gene therapy company falls after new FDA appointment
Vinay Prasad has been named the new director of the FDA's Center for Biologics Evaluation and Research, causing concern among...
Europe is under pressure to raise its drug prices
When AstraZeneca CEO Pascal Soriot presented this year's Q1 report, he once again took the opportunity to warn that Europe's low...